Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study
Clinical trial NCT06340334 · COMPLETED
Trial details
- NCT number
- NCT06340334
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-31
- Primary completion
- 2025-09-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.